1. Role of non-coding RNAs in esophageal carcinoma
   Su-Na Zhou, 2020, World Chinese Journal of Digestology CrossRef
2. Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
   Denggang Fu et al, 2020, Frontiers in Genetics CrossRef
3. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
   Ling Wei et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
   Guangtao Pan et al, 2021, Cancer Communications CrossRef
5. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4
   Yuelong Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
6. Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
   Feng Li et al, 2020, Current Pharmacology Reports CrossRef
7. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
   Jiabei Zhou et al, 2020, Frontiers in Pharmacology CrossRef
8. PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression
   Xiao Han et al, 2021, Frontiers in Oncology CrossRef
9. MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma
   Qi-Ying Wei et al, 2024, World Journal of Gastroenterology CrossRef